ELF: The First of its Kind Blood Test for Patients with Advanced Fibrosis due to NASH

Chief Medical Officer, Dr. Chuck Cooper, speaks with Dr. Melanie Pollan, Head of Scientific & Clinical Consulting about the Enhanced Liver Fibrosis (ELF) Test. In this session they will discuss: current challenges in the treatment of NAFLD/NASH, the critical role the laboratory plays in managing these patients, and how the ELF Test has the potential to improve patient outcomes in patients with advanced fibrosis due to NASH, especially with the new inclusion in the AACE Clinical Practice Guidelines (released May 2022).